Go Unlimited with Magzter GOLD

Go Unlimited with Magzter GOLD

Get unlimited access to 9,500+ magazines, newspapers and Premium stories for just

$149.99
 
$74.99/Year

Try GOLD - Free

Metal detector, cornerstone in quality management

Chronicle Pharmabiz

|

September 18, 2025

IDENTIFYING the source of contamination and maintaining quality norms and standards of hygiene can help manufacture safe and quality products stipulated to government norms.

- Dr D Mandal

Metal detector is a key cornerstone in quality control (QC) management for pharmaceutical processing sector. Metal detection forms a key part of product quality assurance (QA) in pharmaceuticals and helping to prove the quality of manufacturing process and compliance with regulations.

Currently available metal detectors utilize latest digital signal processing technology to detect and reject ferrous and nonferrous metals. Latest pharmaceutical detectors have advantages such as highest processing power, superior speed, accuracy with additional features like current good manufacturing practices, design and construction suited for the US health regulatory compliance and meet the demanding quality standards required by the industry.

Advancing quality inspection system

Pharmaceutical products safety norms and legislation continue to come under highly increasing scrutiny. Thorough risk assessments are enabled by the separation and speciation of elements in a drug product, allowing for more detailed evaluations of both the benefits and risks presented by elements within a particular sample.

More and more studies demonstrate that free elements and various bound states differ greatly in toxicity, the speciation of elements will become even more critical almost any stage of drug development and manufacturing, impurities, contaminants, and residuals can be introduced into pharmaceuticals and biopharmaceuticals.

The presence of elemental impurities in raw materials, APIs, drug product, and packaging materials can cause significant disruption to even the most robust path-to-market, as drug products will not comply with necessary regulations to ensuring product safety and efficacy.

MORE STORIES FROM Chronicle Pharmabiz

Chronicle Pharmabiz

Chromatography: Detecting volatile organic compounds

CHROMATOGRAPHY is a method or analytical process for separating mixtures based on differences in the speed at which they migrate over or through a stationary phase. This process can separate complex mixtures of chemicals or proteins into their various different components.

time to read

4 mins

September 18, 2025

Chronicle Pharmabiz

Bulk drugs, intermediates imports grow 5 per cent

IMPORTS of bulk drugs and intermediates to India registered a growth of 5% in the month of July, 2025, while the cumulative imports for the first four months of the fiscal year witnessed a decline of 3.8%.

time to read

2 mins

September 18, 2025

Chronicle Pharmabiz

Chronicle Pharmabiz

Gandhi Automations offers PRIME NEO for clean environment

GANDHI Automations Pvt Ltd, India's number one entrance automation and loading bay equipment company, offers multi-composites and highperformance door, PRIME NEO for clean environments.

time to read

1 mins

September 18, 2025

Chronicle Pharmabiz

Healthcare shifts to patient-centric infra

THE healthcare sector in the country is undergoing a transformative shift, placing patients and sustainability at the heart of its infrastructure development. Hospitals and medical facilities across the country are increasingly adopting designs that prioritize patient comfort, healing environments, and eco-friendly operations.

time to read

2 mins

September 18, 2025

Chronicle Pharmabiz

Tech to enhance various aspects of healthcare: Experts

INDIAN digital technology is placing engineers as the pivot of healthcare innovation and recognizing them as the fulcrum for transforming the future of medical care. Their expertise is crucial in integrating technology with healthcare systems, ensuring efficient, personalized, and scalable solutions that meet the evolving needs of the population.

time to read

1 mins

September 18, 2025

Chronicle Pharmabiz

KPRDO opposes Abbott's move restricting distribution of Freestyle Libre

THE Karnataka Pharma Retailers & Distributors Organization (KPRDO) has reported a sharp increase in patient enquiries and concerns over the availability of Freestyle Libre sensors, following Abbott's recent decision to restrict distribution of the popular glucose monitoring device exclusively to online platforms.

time to read

2 mins

September 18, 2025

Chronicle Pharmabiz

KEA to handle D Pharm seat allotment for govt, private quotas

KARNATAKA government has decided that seat allotment for D Pharmacy (D Pharm) courses from the academic year 2025-26 for both the government and private quota seats will be handled through the Karnataka Examinations Authority (KEA).

time to read

2 mins

September 18, 2025

Chronicle Pharmabiz

CRC Press releases book on Ashwagandha

CRC Press, Taylor and Francis Group have released a dedicated book on Ashwagandha: Potential Drug Candidate from Ancient Ayurvedic Remedy. The editors are Dilip Ghosh and Benny Antony.

time to read

1 mins

September 18, 2025

Chronicle Pharmabiz

Indian life sciences charts a pathway for AI-driven regulatory submissions

INDIAN life sciences sector is charting a transformative growth story, one that will position the country as a leader in Al-driven regulatory submissions and data standardization.

time to read

2 mins

September 18, 2025

Chronicle Pharmabiz

'GST restructuring as a game-changing step'

THE Federation of Pharmaceutical Entrepreneurs (FOPE), Karnataka Drugs and Pharmaceutical Manufacturers Association (KDPMA), consultancy majors Grant Thornton Bharat and EY have underscored that the Union govť's move on GST restructuring is a game-changing step.

time to read

1 min

September 18, 2025

Listen

Translate

Share

-
+

Change font size